Home › Knowledge › Medicare Advantage
Vedanth Bhartee
Writer · Reviewed by Richard ChanUpdated Jun 12, 2026
5 min read
Medicare Part D plans frequently cover Farxiga, but the medication is often placed on a higher formulary tier, leading to higher copayments.
Beneficiaries who reach the catastrophic coverage phase of their Part D plan will experience significantly reduced out-of-pocket costs for Farxiga.
The Extra Help program can assist eligible low-income Medicare beneficiaries in reducing their copayments and premiums for medications like Farxiga.
Farxiga stands as a monumental, frequently prescribed medication critical for treating devastating conditions like type 2 diabetes, heart failure, and chronic kidney disease. Because of its massive scope, the cost and availability of this drug intimately affect a huge portion of the Medicare population.
Attempting to understand the true cost of Farxiga while relying on Medicare can feel like deciphering a foreign language. This article aggressively cuts through the confusion, clarifying the exact factors that dictate its price and its coverage under Medicare, empowering you to navigate your healthcare expenses without fear.
Farxiga, scientifically known by its generic name dapagliflozin, is a powerful member of a class of medications known as SGLT2 inhibitors. While it is primarily championed to fiercely manage type 2 diabetes, it has also secured vital FDA approval to treat highly vulnerable patients suffering from heart failure and chronic kidney disease.
Farxiga works by brilliantly forcing the kidneys to partially block the reabsorption of both sugar and sodium. This vital action not only helps aggressively manage dangerous blood glucose levels but also delivers profound secondary health benefits to the heart and kidneys.
The incredibly widespread reliance on this medication makes perfect sense when you confront the statistics: roughly 28% of all Medicare beneficiaries are battling diabetes, 15% have been diagnosed with heart failure, and a terrifying 1 in 4 are quietly fighting chronic kidney disease.
According to the drug's manufacturer, Medicare Part D (Prescription Drugs) plans step up to cover Farxiga without requiring frustrating prior authorization for the vast majority of beneficiaries.
However, you must understand that coverage is never a one-size-fits-all guarantee; it can swing wildly between different Medicare Part D plans.
The absolute only way to confidently know if your specific plan covers Farxiga is by rigorously checking your Part D plan's formulary (the master, heavily guarded list of drugs your plan actually agrees to pay for).
While strict federal regulations heavily pressure Part D plans to cover most FDA-approved medications, Medicare allows private insurers a frustrating amount of flexibility in exactly how they structure that coverage and assign pricing tiers.
This starkly means that while Farxiga is highly likely to be covered, the true depth of that coverage and your associated out-of-pocket costs can look radically different from one plan to the next.
Crucially, it is absolutely essential to note that Farxiga was powerfully selected as one of the very first ten drugs targeted for aggressive Medicare drug price negotiations under the monumental Inflation Reduction Act (IRA).
This intense negotiation process kicked off in 2026, with the newly slashed prices legally taking effect in 2026. This historic move is squarely aimed at radically increasing the accessibility and financial affordability of life-saving prescription drugs for all Medicare beneficiaries.
The agonizing cost of Farxiga while on Medicare is not a fixed number; it can violently fluctuate based on several massive factors, heavily including the generosity of your specific Medicare plan, the pharmacy you loyally use, and whether you are fortunate enough to qualify for federal assistance programs.
Looking at the data from 2018 through 2022, the brutal reality is that the average annual out-of-pocket spending on Farxiga per enrollee spiked by a painful 26%, climbing from $206 to $260—equating to an average monthly burden of roughly $22.
Furthermore, your specific cost may also be heavily manipulated by the exact dosage your doctor prescribes.
Farxiga is currently available in both 5 mg and 10 mg tablets, and the retail price may shift slightly between these two strengths. Additionally, the sheer quantity of medication you purchase at the counter—such as opting for a 30-day versus a 90-day supply—can powerfully alter your overall out-of-pocket cost.
It is profoundly important to reiterate that Farxiga is the expensive brand-name formulation for the generic drug dapagliflozin. While the general rule of thumb is that generic drugs cost significantly less than their brand-name counterparts, the pharmaceutical market is complex, and pricing for this specific medication does not always follow that comforting logic.
No. You must never assume that all Medicare plans guarantee coverage for Farxiga.
Medicare Advantage and Medicare Part D plans enforce wildly different copay structures and tier assignments for expensive brand-name drugs like Farxiga. You must relentlessly review your specific plan's details or directly contact your insurance provider to fully grasp your actual coverage and lock down your potential out-of-pocket costs before you ever reach the pharmacy counter.
Yes, if the cost of Farxiga is breaking your budget, there are powerful alternatives that Medicare may be far more willing to cover. A highly notable alternative is Jardiance, which is another potent SGLT2 inhibitor. While Jardiance and Farxiga share highly similar chemical structures and deploy nearly identical mechanisms of action within the body, they are not exact, identical copies.
Be warned: the coverage and out-of-pocket costs of these specific alternatives can still vary wildly under different Medicare plans, exactly as they do for Farxiga.
If you are desperately considering an alternative medication to save money, you must rigorously check your plan's formulary and urgently discuss these potential options with your trusted healthcare provider.
They are your best ally in determining the absolute most appropriate medication that honors both your fragile health needs and your very real financial situation.
If you are agonizing over how to afford Farxiga, please know that there are several powerful lifelines available to you: